MAPT and Alzheimer disease: Compared with visual read tau-negative participants of the same diagnostic group, temporal meta-ROI SUVr was higher in visual read tau-positive CU participants (p < 0.001), participants with AD (p < 0.001), and participants with DLB (p = 0.03).